Irinel Popescu: Cancer, Transplant Hepatic & Sănătatea Ficatului – Radio România Cultural
As the world observes World Cancer Day on February 4th, a critical focus remains on prevention, early detection and innovative treatment strategies. In Romania, approximately 100,000 people receive a new cancer diagnosis each year, making it the second leading cause of death after cardiovascular disease. Over 500,000 cancer patients are currently registered in the country, and statistics indicate that nearly 20% of deaths are attributable to cancer, with a cumulative risk of developing the disease reaching over 28% by age 75.
The Importance of Proactive Liver Cancer Monitoring
Professor Doctor Irinel Popescu, a leading figure in Romanian medicine – a Professor at the University of Medicine and Pharmacy Carol Davila in Bucharest, a titular member of the Romanian Academy’s Medical Sciences Section, and an associate member of the French National Academy of Medicine – emphasizes the importance of regular monitoring for individuals with a history of hepatitis B or C. He states that undergoing hepatic ultrasound and monitoring alpha-fetoprotein levels every six to twelve months can contribute to the early detection of liver tumors and, successful treatment.
Professor Popescu’s pioneering work extends beyond transplantation. He introduced robotic surgery in 2008 within the “George Emil Palade” research platform at the University of Medicine and Pharmacy “Carol Davila.” His contributions have been recognized with the highest distinction of the Romanian Orthodox Patriarchate, the Patriarchal Cross, awarded in 2012 for his life-saving work in transplantation – described as “to give life beyond death.” He currently teaches within the interdisciplinary master’s programme “Christian Spirituality and Healthy Life” at the Justinian Patriarch Faculty of Theology of the University of Bucharest.
Advancements in Liver Cancer Treatment
Current treatment options for hepatocellular carcinoma include surgical resection, liver transplantation for localized tumors, radio or chemo-embolization, and increasingly, immunotherapy. These personalized oncological treatments represent significant progress in the fight against liver cancer.
The lack of national programmes focused on cancer education, prevention, screening, and early detection is cited as a contributing factor to the concerning statistics. Globally, over 50% of tumors are estimated to be preventable through vaccination against hepatitis B and the Human Papillomavirus (HPV), as well as by avoiding smoking and excessive alcohol consumption.
Frequently Asked Questions
What types of primary tumors metastasize to the liver?
The source does not specify which types of primary tumors metastasize to the liver, only that some do.
What therapeutic approach can be adopted when tumors metastasize to the liver?
The source does not detail specific therapeutic approaches for metastatic tumors, but mentions surgical resection, liver transplantation, radio or chemo-embolization, and immunotherapy as treatments for hepatocellular carcinoma.
How does chronic liver damage, including hepatic fibrosis from non-alcoholic steatosis, impact the risk of liver cancer?
The source indicates that chronic liver damage, including hepatic fibrosis from non-alcoholic steatosis, represents an additional risk factor regarding liver cancer.
Considering the challenges and advancements discussed, what role do you believe individual lifestyle choices play in mitigating cancer risk?